Jalen Hurts placed on IR after calf blood clot; Tanner McKee to start as Eagles face at least four-week hole

The Eagles' decision followed multiple consultations with outside experts and came after follow-up imaging showed the clot had shifted compared with earlier scans, according to team and league reports. That apparent movement — not just the presence of a clot — reportedly pushed the organization toward a more cautious posture.

Placing Hurts on IR triggers a minimum absence of four weeks; if doctors prescribe anticoagulants (blood thinners) for treatment, playing while on those drugs isn’t safe and would extend his time away from the field. The Eagles have framed their choice as one guided by health and safety, not timetable management.

Tanner McKee will start in Hurts’ place, with rookie Cole Payton providing depth. The Eagles face three NFC East opponents during the next stretch, and losing a franchise-caliber starter complicates Philadelphia’s short-term playoff picture and offensive continuity.

Beyond Xs-and-Os, coaching staff must balance play-calling to protect McKee and the offensive line while trying to preserve a competitive record during a delicate stretch of the schedule.

There’s a blunt trade-off at work: pursue an approach that might clear Hurts sooner but increases medical risk, or accept a longer absence for greater safety. The club’s consultations with multiple physicians underscore that the timeline is a medical determination — not an arbitrary roster decision.

How the Eagles resolve that trade-off will also influence roster moves (do they add an experienced backup?), short-term play-calling and the team’s posture at the trade deadline or roster-deadline windows.